Research location
Lauderhill
Florida, United States
Advertisement
Research activity in Lauderhill
Florida, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 101 trials and 102 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Lauderhill
101 linked trials · page 2 of 3Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive DisorderNCT03002077 · 2017-02-03 · 1 site observation
COMPLETED
Extension Study of Pimavanserin for the Adjunctive Treatment of SchizophreniaNCT03121586 · 2017-01-01 · 1 site observation
TERMINATED
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With AntipsychoticsNCT02953639 · 2016-11-30 · 1 site observation
COMPLETED
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive DisorderNCT02951988 · 2016-11-13 · 1 site observation
COMPLETED
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)NCT02970305 · 2016-11-04 · 1 site observation
COMPLETED
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)NCT02943564 · 2016-11-01 · 1 site observation
COMPLETED
Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)NCT02970292 · 2016-10-26 · 1 site observation
COMPLETED
A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With SchizophreniaNCT02873208 · 2016-08-07 · 1 site observation
COMPLETED
Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With SchizophreniaNCT02892422 · 2016-08-01 · 1 site observation
COMPLETED
Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar DepressionNCT02600507 · 2016-03-07 · 1 site observation
COMPLETED
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)NCT02694328 · 2016-03-02 · 1 site observation
COMPLETED
Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar DepressionNCT02600494 · 2015-12-15 · 1 site observation
COMPLETED
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeNCT02446132 · 2015-11-13 · 1 site observation
TERMINATED
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)NCT02452892 · 2015-09-01 · 1 site observation
COMPLETED
A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of SchizophreniaNCT02477020 · 2015-07-01 · 1 site observation
COMPLETED
Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive DisorderNCT02431806 · 2015-06-23 · 1 site observation
COMPLETED
A Study of Vilazodone in Pediatric Patients With Major Depressive DisorderNCT02436239 · 2015-05-02 · 1 site observation
COMPLETED
Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)NCT02372799 · 2015-02-28 · 1 site observation
COMPLETED
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaNCT02320032 · 2014-12-01 · 1 site observation
COMPLETED
A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.NCT02281773 · 2014-11-10 · 1 site observation
COMPLETED
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 StudyNCT02158533 · 2014-05-01 · 1 site observation
COMPLETED
A Long-Term Safety Study of ALKS 5461NCT02141399 · 2014-05-01 · 1 site observation
COMPLETED
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase SchizophreniaNCT02008773 · 2014-03-26 · 1 site observation
COMPLETED
Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)NCT01912196 · 2013-10-01 · 1 site observation
COMPLETED
An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of SchizophreniaNCT01939548 · 2013-10-01 · 1 site observation
TERMINATED
A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's AgitationNCT01862640 · 2013-07-11 · 1 site observation
COMPLETED
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714713 · 2013-06-01 · 1 site observation
COMPLETED
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714661 · 2012-10-01 · 1 site observation
COMPLETED
NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)NCT01688037 · 2012-09-01 · 1 site observation
COMPLETED
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With SchizophreniaNCT01529515 · 2012-05-01 · 1 site observation
COMPLETED
Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive DisorderNCT01564862 · 2012-04-01 · 1 site observation
COMPLETED
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)NCT01500200 · 2011-12-01 · 1 site observation
COMPLETED
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant TreatmentNCT01457677 · 2011-12-01 · 1 site observation
COMPLETED
A Long-Term Safety Study of Pomaglumetad Methionil in SchizophreniaNCT01487083 · 2011-12-01 · 1 site observation
TERMINATED
Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With SchizophreniaNCT01488929 · 2011-12-01 · 1 site observation
COMPLETED
Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionNCT01364649 · 2011-06-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01305408 · 2011-03-01 · 1 site observation
COMPLETED
A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of SchizophreniaNCT01234779 · 2011-02-01 · 1 site observation
COMPLETED
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)NCT01235559 · 2010-12-01 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of SchizophreniaNCT01192880 · 2010-11-01 · 1 site observation
COMPLETED
Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderNCT01153009 · 2010-06-01 · 1 site observation
COMPLETED
Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01121536 · 2010-04-30 · 1 site observation
TERMINATED
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01072630 · 2010-03-01 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT01072929 · 2010-01-01 · 1 site observation
COMPLETED
Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative SymptomsNCT00922272 · 2009-09-14 · 1 site observation
COMPLETED
Study in Adolescents With Schizophrenia or Bipolar DisorderNCT00982020 · 2009-09-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With SchizophreniaNCT00772005 · 2008-09-01 · 1 site observation
COMPLETED
A Safety, Efficacy and Tolerability Study of SEP-225289NCT00584974 · 2007-12-01 · 1 site observation
COMPLETED
Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderNCT00481195 · 2007-06-01 · 1 site observation
COMPLETED
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By ExemestaneNCT00036270 · 2001-08-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.